Advertisement
Screener

Eagle Pharmaceuticals, Inc. Form 10-K: Annual report

Eagle Pharmaceuticals, Inc. Form 10-K: Annual report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-03-23: Form 10-K; Period of report 2022-12-31; Description 10-K; Document egrx-20221231.htm.
  • 2022-03-08: Form 10-K; Period of report 2021-12-31; Description 10-K; Document egrx-20211231.htm.
  • 2021-03-05: Form 10-K; Period of report 2020-12-31; Description 10-K; Document egrx-20201231.htm.
  • 2020-03-02: Form 10-K; Period of report 2019-12-31; Description 10-K; Document egrx10k2019.htm.
FiledFormPeriod of reportDescriptionDocument
2023-03-2310-K2022-12-3110-Kegrx-20221231.htm
2022-03-0810-K2021-12-3110-Kegrx-20211231.htm
2021-03-0510-K2020-12-3110-Kegrx-20201231.htm
2020-03-0210-K2019-12-3110-Kegrx10k2019.htm
2019-02-2810-K2018-12-3110-Kegrx_10kx2018.htm
2018-02-2610-K2017-12-3110-Kegrx_10kx2017.htm
2017-03-1510-K2016-12-3110-Kcopyofegrx_10kx2016.htm
2016-02-2910-K2015-12-3110-Kegrx_10kx2015.htm
2014-12-2210-K2014-09-3010-Kegrx_q4x2014.htm